4.7 Article

ILC2s regulate adaptive Th2 cell functions via PD-L1 checkpoint control

期刊

JOURNAL OF EXPERIMENTAL MEDICINE
卷 214, 期 9, 页码 2507-2521

出版社

ROCKEFELLER UNIV PRESS
DOI: 10.1084/jem.20170051

关键词

-

资金

  1. Science Foundation Ireland [10/IN.1/B3004]
  2. Wellcome Trust [092530/Z/10/Z]
  3. National Children's Research Centre
  4. Wellcome Trust [092530/Z/10/Z] Funding Source: Wellcome Trust
  5. MRC [MC_U105178805] Funding Source: UKRI
  6. Science Foundation Ireland (SFI) [10/IN.1/B3004] Funding Source: Science Foundation Ireland (SFI)
  7. Medical Research Council [MC_U105178805] Funding Source: researchfish

向作者/读者索取更多资源

Group 2 innate lymphoid cells (ILC2s) are important effector cells driving the initiation of type 2 immune responses leading to adaptive T helper 2 (Th2) immunity. Here we show that ILC2s dynamically express the checkpoint inhibitor molecule PD-L1 during type 2 pulmonary responses. Surprisingly, PD-L1 : PD-1 interaction between ILC2s and CD4(+) T cells did not inhibit the T cell response, but PD-L1-expressing ILC2s stimulated increased expression of GATA3 and production of IL-13 by Th2 cells both in vitro and in vivo. Conditional deletion of PD-L1 on ILC2s impaired early Th2 polarization and cytokine production, leading to delayed worm expulsion during infection with the gastrointestinal helminth Nippostrongylus brasiliensis. Our results identify a novel PD-L1-controlled mechanism for type 2 polarization, with ILC2s mediating an innate checkpoint to control adaptive T helper responses, which has important implications for the treatment of type 2 inflammation.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据